These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. Angulo JA J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626 [TBL] [Abstract][Full Text] [Related]
24. Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission. George SR; Kertesz M Peptides; 1987; 8(3):487-92. PubMed ID: 2889200 [TBL] [Abstract][Full Text] [Related]
25. The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors. Westfall TC; Grant H; Naes L; Meldrum M Eur J Pharmacol; 1983 Aug; 92(1-2):35-42. PubMed ID: 6628536 [TBL] [Abstract][Full Text] [Related]
26. Increase of striatal Met5-enkephalin-Arg6-Phe7 (YGGFMRF) content elicited by long-term treatment with haloperidol. Chou J; Tang J; Yang HY; Costa E J Pharmacol Exp Ther; 1984 Apr; 229(1):171-4. PubMed ID: 6368796 [TBL] [Abstract][Full Text] [Related]
27. The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats. Herman ZS; Trzeciak HI; Kowalski J; Obuchowicz E; Huzarska M Pol J Pharmacol Pharm; 1991; 43(5):421-32. PubMed ID: 1688094 [No Abstract] [Full Text] [Related]
28. Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946 [TBL] [Abstract][Full Text] [Related]
29. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510 [TBL] [Abstract][Full Text] [Related]
30. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Engber TM; Boldry RC; Kuo S; Chase TN Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580 [TBL] [Abstract][Full Text] [Related]
31. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum. Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853 [TBL] [Abstract][Full Text] [Related]
32. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. Tedford CE; Crosby G; Iorio LC; Chipkin RE Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318 [TBL] [Abstract][Full Text] [Related]
33. Local and remote effects of intra-caudate administration of GABA-related drugs on Met-enkephalin release in the basal ganglia. Bourgoin S; Artaud F; Cesselin F; Glowinski J; Hamon M Brain Res; 1985 Dec; 361(1-2):361-72. PubMed ID: 3936593 [TBL] [Abstract][Full Text] [Related]
34. Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Trujillo KA; Day R; Akil H Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215 [TBL] [Abstract][Full Text] [Related]
35. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. Braun AR; Laruelle M; Mouradian MM J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170 [TBL] [Abstract][Full Text] [Related]
36. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
37. Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? Imperato A; Obinu MC; Dazzi L; Gessa GL Eur J Pharmacol; 1994 Jan; 251(2-3):271-9. PubMed ID: 7908640 [TBL] [Abstract][Full Text] [Related]
38. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666 [TBL] [Abstract][Full Text] [Related]
39. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of striatal enkephalin release in vivo from steady state levels and turnover rates of the tripeptide Tyr-Gly-Gly. Llorens-Cortes C; Gros C; Schwartz JC NIDA Res Monogr; 1986; 75():275-8. PubMed ID: 3123945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]